TF and hydrops fetalis: To date, the European Society of Cardiology (ESC) HF guidelines advocate testing all HF patients for anaemia and iron deficiency (including serum ferritin and transferrin saturations), and recommend treatment with IV ferric carboxymaltose (Class IIA, level of Evidence A recommendation) for symptomatic HF patients with iron deficiency to improve HF symptoms and quality of life [1].